Shirkadda Israa’iil ee Teknoolojiyada Caqliga Fudud (AI) ee CytoReason ayaa ballaarisay iskaashigeeda daahfurka daawooyinka oo ay la gashay Sanofi oo ka socota Faransiiska
Shirkadda Israa'iili ee tignoolajiyada maskaxda (AI) ee CytoReason ayaa ballaarisay iskaashigeedii horumarinta dawooyinka ee Sanofi, iyadoo saxiixday heshiis cusub oo soconaya sanado badan, qiimihiisuna gaarayo ilaa $16 milyan, taasoo calaamad u ah heshiiskeedii shanaad ee ganacsi.